Optimising pharmacokinetics via ADMET, bioactivity of Zr substituted samarium-doped ceria nanomaterials Online publication date: Tue, 10-Oct-2023
by Bradha Madhavan; A. Suvitha; Nagaraj Balakrishnan; Ananth Steephen; P. Ajay
International Journal of Nanotechnology (IJNT), Vol. 20, No. 5/6/7/8/9/10, 2023
Abstract: The properties of ADMEs, bioactivity and restricted molecular medicinal chemistry were analysed via Swiss ADME in order to facilitate drug development. The important activities of absorption, distribution, metabolism, excretion and toxicity (ADMET) in optimising pharmacokinetics and assessing the Ce0.8-x ZrxSm0.2O2−δ compounds were estimated. Six physico-chemical characteristics, bioactivity radar, donor acceptors and molar refractivity are being tested. In search of significant improvement in CeO2 fluorite structure, a promising doping, co-doping approach was adopted. By varying the mole ratios of samarium dopant and Zr substitution, the Ce0.8-xZrxSm0.2O2−δnanomaterials were synthesised through simple chemical process. Basic electronic structure calculation, bonding graph and crystallographic representation were analysed via materials project tool. From the bonding graph, material design, synthesis glitches and stability assessments from the energies were calculated. ADMET Predictor is a product tool that rapidly and reliably forecasts more than 40 properties, including dissolvability, log P, CYP digestion positions and mutagenicity of Ames. Hence, these efforts are promising in monitoring pharmacokinetics via bio-electronics sensors and interfaces.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nanotechnology (IJNT):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com